Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Aligos Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aligos Therapeutics Inc. June 25, 202695.7%
-
Aligos Therapeutics Inc. July 20, 202386.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 25, 2023 | Aligos Therapeutics Inc. | Open-market purchase | +7,933,601 | $0.76 | $6,029,537 |
Questions about Carole Nuechterlein
What boards is Carole Nuechterlein on?
Carole Nuechterlein sits on the boards of Aligos Therapeutics Inc. and Freenome Inc.
How long has Carole Nuechterlein served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.